BM0027
BMS-870145
≥98% (HPLC)
别名:
BMS 870145, BMS-870145-01, N-[2-[4-(4-Chlorophenyl)-5-fluoro-2,3-dihydro-7-hydroxy-3,3-dimethyl-1H-indol-1-yl]phenyl]-N′-[4-(trifluoromethoxy)phenyl]-urea
SMILES string
FC1=CC(O)=C2C(C(C)(C)CN2C3=C(NC(NC4=CC=C(OC(F)(F)F)C=C4)=O)C=CC=C3)=C1C5=CC=C(Cl)C=C5
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 20 mg/mL, clear
storage temp.
room temp
Quality Level
Biochem/physiol Actions
BMS-870145 is an orally available, potent and selective P2Y1 purinergic receptor antagonist.
BMS-870145 is an orally available, potent and selective P2Y1 purinergic receptor antagonist. BMS-870145 demonstrated similar antithrombotic efficacy with less bleeding compared with P2Y12 antagonist prasugrel in rabbits.
Features and Benefits
BMS-870145 is available through a partnership with Bristol-Myers Squibb (BMS). To learn more and view other BMS compounds, visit sigma.com/BMS.
Legal Information
Sold for research purposes only under agreement from BMS.
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持